Methylprednisolone Acetate — Class I drug recall D-109-2013
Terminated recall by New England Compounding Center, reported 2013-01-09, distributed nationwide. Non-Sterility
| Recall number | D-109-2013 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | New England Compounding Center, Framingham, MA, United States |
| Recall initiated | 2012-09-26 |
| Classified | 2012-12-31 |
| Reported by FDA | 2013-01-09 |
| Terminated | 2016-10-07 |
| Distributed | Nationwide (US) |
| Quantity | 9,062 vials |
| Reason classes | sterility |
Product
Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA
Reason for recall
Non-Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-109-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.